{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:46:38Z","timestamp":1792014398224,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"SERB Govt. of India","award":["IPA\/2021\/000136"],"award-info":[{"award-number":["IPA\/2021\/000136"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bioprocess Biosyst Eng"],"DOI":"10.1007\/s00449-026-03438-z","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:57:41Z","timestamp":1792011461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tailoring high-cell-density fed-batch fermentation strategies to produce Russell\u2019s viper venom-specific single-domain antibody in E. coli"],"prefix":"10.1007","author":[{"given":"Shivani","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimisha","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohini","family":"Talwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Maravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharvan","family":"Sehrawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogender Pal","family":"Khasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"3438_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/363446a0","volume":"363","author":"C Hamers-Casterman","year":"1993","unstructured":"Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, Bendahman N, Hamers R (1993) Naturally occurring antibodies devoid of light chains. Nature 363:446\u2013448. https:\/\/doi.org\/10.1038\/363446a0","journal-title":"Nature"},{"key":"3438_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095009","volume":"23","author":"M Arbabi-Ghahroudi","year":"2022","unstructured":"Arbabi-Ghahroudi M (2022) Camelid single-domain antibodies: promises and challenges as lifesaving treatments. Int J Mol Sci 23:9009. https:\/\/doi.org\/10.3390\/ijms23095009","journal-title":"Int J Mol Sci"},{"key":"3438_CR3","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1177\/1535370219881129","volume":"244","author":"RJ Hoey","year":"2019","unstructured":"Hoey RJ, Eom H, Horn JR (2019) Structure and development of single domain antibodies as modules for therapeutics and diagnostics. Exp Biol Med (Maywood) 244:1568\u20131576. https:\/\/doi.org\/10.1177\/1535370219881129","journal-title":"Exp Biol Med (Maywood)"},{"key":"3438_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-021-00332-6","volume":"9","author":"Y Asaadi","year":"2021","unstructured":"Asaadi Y, Jouneghani FF, Janani S, Rahbarizadeh F (2021) A comprehensive comparison between camelid nanobodies and single chain variable fragments. Biomark Res 9:87. https:\/\/doi.org\/10.1186\/s40364-021-00332-6","journal-title":"Biomark Res"},{"key":"3438_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/prot.25497","volume":"86","author":"LS Mitchell","year":"2018","unstructured":"Mitchell LS, Colwell LJ (2018) Comparative analysis of nanobody sequence and structure data. Proteins 86:697\u2013706. https:\/\/doi.org\/10.1002\/prot.25497","journal-title":"Proteins"},{"key":"3438_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25189801","volume":"25","author":"M Xu","year":"2024","unstructured":"Xu M, Zhao Z, Deng P, Sun M, Chiu CKC, Wu Y, Wang H, Bi Y (2024) Functional divergence in the affinity and stability of non-canonical cysteines and non-canonical disulfide bonds: insights from a VHH and VNAR study. Int J Mol Sci 25:9801. https:\/\/doi.org\/10.3390\/ijms25189801","journal-title":"Int J Mol Sci"},{"key":"3438_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.tibtech.2014.03.001","volume":"32","author":"T De Meyer","year":"2014","unstructured":"De Meyer T, Muyldermans S, Depicker A (2014) Nanobody-based products as research and diagnostic tools. Trends Biotechnol 32:263\u2013270. https:\/\/doi.org\/10.1016\/j.tibtech.2014.03.001","journal-title":"Trends Biotechnol"},{"key":"3438_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118819","volume":"193","author":"AR Eisa","year":"2025","unstructured":"Eisa AR, Tavassoli Razavi F, Hoseinzadeh A, Haghmorad D, Baharlou R (2025) Nanobody CAR-T cells in cancer: from molecular design to clinical translation. Biomed Pharmacother 193:118819. https:\/\/doi.org\/10.1016\/j.biopha.2025.118819","journal-title":"Biomed Pharmacother"},{"key":"3438_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2025.2583210","volume":"17","author":"A Evers","year":"2025","unstructured":"Evers A, Guarnera E, Pekar L, Zielonka S (2025) From discovery to the clinic: structural insights, engineering options, clinical, and \u201cnext wave\u201d applications of camelid-derived single-domain antibodies. MAbs 17:2583210. https:\/\/doi.org\/10.1080\/19420862.2025.2583210","journal-title":"MAbs"},{"key":"3438_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27115080","volume":"27","author":"TS Jakobsen","year":"2026","unstructured":"Jakobsen TS, Kaptain K, Pedersen K, Adsersen RL, Aagaard L, Askou AL, Corydon TJ (2026) The promise of single-domain antibodies as ocular therapeutics: a narrative review. Int J Mol Sci 27:5080. https:\/\/doi.org\/10.3390\/ijms27115080","journal-title":"Int J Mol Sci"},{"key":"3438_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.863012","volume":"13","author":"R Ben Abderrazek","year":"2022","unstructured":"Ben Abderrazek R, Ksouri A, Idoudi F, Dhaouadi S, Hamdi E, Vincke C, Farah A, Benlasfar Z, Majdoub H, El Ayeb M, Muyldermans S, Bouhaouala-Zahar B (2022) Neutralizing dromedary-derived nanobodies against BotI-like toxin from the most hazardous scorpion venom in the Middle East and North Africa region. Front Immunol 13:863012. https:\/\/doi.org\/10.3389\/fimmu.2022.863012","journal-title":"Front Immunol"},{"key":"3438_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2024.108057","volume":"249","author":"A Oghalaie","year":"2024","unstructured":"Oghalaie A, Hosseininejad-Chafi M, Mejri H, Zareinejad MR, Bouhaouala-Zahar B, Bagheri KP, Mirzahoseini H, Shahbazzadeh D, Behdani M, Kazemi-Lomedasht F (2024) Development and characterization of nanobody against envenomation by Naja naja oxiana. Toxicon 249:108057. https:\/\/doi.org\/10.1016\/j.toxicon.2024.108057","journal-title":"Toxicon"},{"key":"3438_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/vetsci13010098","volume":"13","author":"C Sakamoto","year":"2026","unstructured":"Sakamoto C, Shitada C, Kiyose N, Miyazaki N, Kamesawa S, Morioka H, Morokuma K, Tomokiyo K, Takahashi M (2026) Complete neutralization of tetanus neurotoxin by alpaca-derived trivalent nanobodies aimed at veterinary medical applications. Vet Sci 13:98. https:\/\/doi.org\/10.3390\/vetsci13010098","journal-title":"Vet Sci"},{"key":"3438_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jconrel.2020.04.030","volume":"323","author":"MM Deken","year":"2020","unstructured":"Deken MM, Kijanka MM, Beltran Hernandez I, Slooter MD, de Bruijn HS, van Diest PJ, van Bergen En Henegouwen PMP, Lowik C, Robinson DJ, Vahrmeijer AL, Oliveira S (2020) Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session. J Control Release 323:269\u2013281. https:\/\/doi.org\/10.1016\/j.jconrel.2020.04.030","journal-title":"J Control Release"},{"key":"3438_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/diagnostics7040052","volume":"7","author":"CH Leow","year":"2017","unstructured":"Leow CH, Fischer K, Leow CY, Cheng Q, Chuah C, McCarthy J (2017) Single domain antibodies as new biomarker detectors. Diagnostics (Basel) 7:52. https:\/\/doi.org\/10.3390\/diagnostics7040052","journal-title":"Diagnostics (Basel)"},{"key":"3438_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biom10121663","volume":"10","author":"E Soetens","year":"2020","unstructured":"Soetens E, Ballegeer M, Saelens X (2020) An inside job: applications of intracellular single domain antibodies. Biomolecules 10:1663. https:\/\/doi.org\/10.3390\/biom10121663","journal-title":"Biomolecules"},{"key":"3438_CR17","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.2147\/IJN.S107194","volume":"11","author":"Y Wang","year":"2016","unstructured":"Wang Y, Fan Z, Shao L, Kong X, Hou X, Tian D, Sun Y, Xiao Y, Yu L (2016) Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications. Int J Nanomed 11:3287\u20133303. https:\/\/doi.org\/10.2147\/IJN.S107194","journal-title":"Int J Nanomed"},{"key":"3438_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/immhor\/vlaf012","author":"S Dahiya","year":"2025","unstructured":"Dahiya S, Singh S, Bhati GK, Sehrawat S (2025) In vitro and in vivo neutralization of Dengue virus by a single domain antibody. Immunohorizons. https:\/\/doi.org\/10.1093\/immhor\/vlaf012","journal-title":"Immunohorizons"},{"key":"3438_CR19","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1111\/febs.15515","volume":"288","author":"S Muyldermans","year":"2021","unstructured":"Muyldermans S (2021) A guide to: generation and design of nanobodies. FEBS J 288:2084\u20132102. https:\/\/doi.org\/10.1111\/febs.15515","journal-title":"FEBS J"},{"key":"3438_CR20","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1177\/2472555219853235","volume":"24","author":"J Woods","year":"2019","unstructured":"Woods J (2019) Selection of functional intracellular nanobodies. SLAS Discov 24:703\u2013713. https:\/\/doi.org\/10.1177\/2472555219853235","journal-title":"SLAS Discov"},{"key":"3438_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00253-017-8644-3","volume":"102","author":"Y Liu","year":"2018","unstructured":"Liu Y, Huang H (2018) Expression of single-domain antibody in different systems. Appl Microbiol Biotechnol 102:539\u2013551. https:\/\/doi.org\/10.1007\/s00253-017-8644-3","journal-title":"Appl Microbiol Biotechnol"},{"key":"3438_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00655","volume":"11","author":"H Bailon Calderon","year":"2020","unstructured":"Bailon Calderon H, Yaniro Coronel VO, Caceres Rey OA, Colque Alave EG, Leiva Duran WJ, Padilla Rojas C, Montejo Arevalo H, Garcia Neyra D, Galarza Perez M, Bonilla C, Tintaya B, Ricciardi G, Smiejkowska N, Romao E, Vincke C, Levano J, Celys M, Lomonte B, Muyldermans S (2020) Development of nanobodies against hemorrhagic and myotoxic components of Bothrops atrox snake venom. Front Immunol 11:655. https:\/\/doi.org\/10.3389\/fimmu.2020.00655","journal-title":"Front Immunol"},{"key":"3438_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pep.2020.105645","volume":"172","author":"A de Marco","year":"2020","unstructured":"de Marco A (2020) Recombinant expression of nanobodies and nanobody-derived immunoreagents. Protein Expr Purif 172:105645. https:\/\/doi.org\/10.1016\/j.pep.2020.105645","journal-title":"Protein Expr Purif"},{"key":"3438_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24162860","author":"D Li","year":"2019","unstructured":"Li D, Ji F, Huang C, Jia L (2019) High expression achievement of active and robust anti-beta2 microglobulin nanobodies via E. coli hosts selection. Molecules. https:\/\/doi.org\/10.3390\/molecules24162860","journal-title":"Molecules"},{"key":"3438_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.630551","volume":"9","author":"A Bhatwa","year":"2021","unstructured":"Bhatwa A, Wang W, Hassan YI, Abraham N, Li XZ, Zhou T (2021) Challenges associated with the formation of recombinant protein inclusion bodies in Escherichia coli and strategies to address them for industrial applications. Front Bioeng Biotechnol 9:630551. https:\/\/doi.org\/10.3389\/fbioe.2021.630551","journal-title":"Front Bioeng Biotechnol"},{"key":"3438_CR26","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1002\/bit.27362","volume":"117","author":"M Schneier","year":"2020","unstructured":"Schneier M, Razdan S, Miller AM, Briceno ME, Barua S (2020) Current technologies to endotoxin detection and removal for biopharmaceutical purification. Biotechnol Bioeng 117:2588\u20132609. https:\/\/doi.org\/10.1002\/bit.27362","journal-title":"Biotechnol Bioeng"},{"key":"3438_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/bab.1544","volume":"64","author":"L Xu","year":"2017","unstructured":"Xu L, Song X, Jia L (2017) A camelid nanobody against EGFR was easily obtained through refolding of inclusion body expressed in Escherichia coli. Biotechnol Appl Biochem 64:895\u2013901. https:\/\/doi.org\/10.1002\/bab.1544","journal-title":"Biotechnol Appl Biochem"},{"key":"3438_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.toxicon.2019.10.240","volume":"172","author":"M Kaur","year":"2019","unstructured":"Kaur M, Dubey A, Khatri M, Sehrawat S (2019) Secretory PLA2 specific single domain antibody neutralizes Russell viper venom induced cellular and organismal toxicity. Toxicon 172:15\u201318. https:\/\/doi.org\/10.1016\/j.toxicon.2019.10.240","journal-title":"Toxicon"},{"key":"3438_CR29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2217\/nnm-2017-0039","volume":"12","author":"V Agrahari","year":"2017","unstructured":"Agrahari V, Hiremath P (2017) Challenges associated and approaches for successful translation of nanomedicines into commercial products. Nanomed (Lond) 12:819\u2013823. https:\/\/doi.org\/10.2217\/nnm-2017-0039","journal-title":"Nanomed (Lond)"},{"key":"3438_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzaf010","author":"A Pejenaute","year":"2025","unstructured":"Pejenaute A, Galvez-Larrosa L, Segovia CM, Herrero-Alfonso P, Fernandez-Ramos D, Lopitz-Otsoa F, Millet O, Peccati F, Jimenez-Oses G, Ortega-Quintanilla G (2025) Improving the production and stability of nanobodies. Protein Eng Des Sel. https:\/\/doi.org\/10.1093\/protein\/gzaf010","journal-title":"Protein Eng Des Sel"},{"key":"3438_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s11671-025-04200-2","volume":"20","author":"Y Wu","year":"2025","unstructured":"Wu Y (2025) Trends in nanobody technology in industrialization. Discov Nano 20:23. https:\/\/doi.org\/10.1186\/s11671-025-04200-2","journal-title":"Discov Nano"},{"key":"3438_CR32","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.procbio.2022.11.024","volume":"124","author":"A Gennari","year":"2023","unstructured":"Gennari A, Simon R, de Andrade BC, Kuhn D, Renard G, Chies JM, Volpato G, Volken de Souza CF (2023) Recombinant production in Escherichia coli of a \u03b2-galactosidase fused to a cellulose-binding domain using low-cost inducers in fed-batch cultivation. Process Biochem 124:290\u2013298. https:\/\/doi.org\/10.1016\/j.procbio.2022.11.024","journal-title":"Process Biochem"},{"key":"3438_CR33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s13206-025-00210-5","volume":"19","author":"YS Kim","year":"2025","unstructured":"Kim YS, Oh SY, Lee H-J, Son SU, Jeong H, Kim H, Jung J, Kim Y-P, Lim E-K, Ahn J (2025) Fab2-SARAH: an\u00a0Escherichia coli-based antibody fragment platform for scalable, cost-effective in vitro diagnostics. BioChip J 19:705\u2013721. https:\/\/doi.org\/10.1007\/s13206-025-00210-5","journal-title":"BioChip J"},{"issue":"1","key":"3438_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12257-024-00149-8","volume":"30","author":"S Mohanty","year":"2024","unstructured":"Mohanty S, Babbal, Chauhan S, Talwar M, Khasa YP (2024) Continuous cell recycling in methylotrophic yeast Pichia pastoris to enhance product yields: a case study with Yarrowia lipolytica lipase Lip2. Biotechnol Bioprocess Eng 30(1):116\u2013131. https:\/\/doi.org\/10.1007\/s12257-024-00149-8","journal-title":"Biotechnol Bioprocess Eng"},{"key":"3438_CR35","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00449-026-03337-3","volume":"49","author":"S Mohanty","year":"2026","unstructured":"Mohanty S, Babbal, Chauhan S, Talwar M, Sharma S, Maravi P, Khasa YP (2026) Designing strategies for high-level production of peptide-N-glycosidase F (PNGase F) from Flavobacterium meningosepticum using high cell density fed-batch culture of E. coli. Bioprocess Biosyst Eng 49:1551\u20131566. https:\/\/doi.org\/10.1007\/s00449-026-03337-3","journal-title":"Bioprocess Biosyst Eng"},{"key":"3438_CR36","doi-asserted-by":"publisher","first-page":"9979","DOI":"10.1007\/s00253-016-7683-5","volume":"100","author":"N Devi","year":"2016","unstructured":"Devi N, Adivitiya, Khasa YP (2016) A combinatorial approach of N-terminus blocking and codon optimization strategies to enhance the soluble expression of recombinant hIL-7 in E. coli fed-batch culture. Appl Microbiol Biotechnol 100:9979\u20139994. https:\/\/doi.org\/10.1007\/s00253-016-7683-5","journal-title":"Appl Microbiol Biotechnol"},{"key":"3438_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12934-022-01972-5","volume":"21","author":"L Li","year":"2022","unstructured":"Li L, Li H, Tian Q, Ge B, Xu X, Chi Y, Zhao H, Liu Y, Jia N, Zhou T, Zhu Y, Zhou Y (2022) Expression and purification of soluble recombinant beta-lactamases using Escherichia coli as expression host and pET-28a as cloning vector. Microb Cell Fact 21:244. https:\/\/doi.org\/10.1186\/s12934-022-01972-5","journal-title":"Microb Cell Fact"},{"key":"3438_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijbiomac.2015.11.062","volume":"83","author":"VK Adivitiya, Dagar","year":"2016","unstructured":"Adivitiya, Dagar VK, Devi N, Khasa YP (2016) High level production of active streptokinase in Pichia pastoris fed-batch culture. Int J Biol Macromol 83:50\u201360. https:\/\/doi.org\/10.1016\/j.ijbiomac.2015.11.062","journal-title":"Int J Biol Macromol"},{"key":"3438_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s13205-022-03293-1","volume":"12","author":"VK Dagar","year":"2022","unstructured":"Dagar VK, Babbal, Mohanty S, Khasa YP (2022) Effect of N-glycosylation on secretion, stability, and biological activity of recombinant human interleukin-3 (hIL-3) in Pichia pastoris. 3 Biotech 12:221. https:\/\/doi.org\/10.1007\/s13205-022-03293-1","journal-title":"3 Biotech"},{"key":"3438_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104549","volume":"25","author":"S Singh","year":"2022","unstructured":"Singh S, Dahiya S, Singh YJ, Beeton K, Jain A, Sarkar R, Dubey A, Tehseen A, Sehrawat S (2022) Robust anti-SARS-CoV2 single domain antibodies cross neutralize multiple viruses. iScience 25:104549. https:\/\/doi.org\/10.1016\/j.isci.2022.104549","journal-title":"iScience"},{"key":"3438_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.enzmictec.2018.10.008","volume":"120","author":"A Babbal","year":"2019","unstructured":"Babbal, Adivitiya, Mohanty S, Khasa YP (2019) Bioprocess optimization for the overproduction of catalytic domain of ubiquitin-like protease 1 (Ulp1) from S. cerevisiae in E. coli fed-batch culture. Enzyme Microb Technol 120:98\u2013109. https:\/\/doi.org\/10.1016\/j.enzmictec.2018.10.008","journal-title":"Enzyme Microb Technol"},{"key":"3438_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jbiosc.2012.09.015","volume":"115","author":"YP Khasa","year":"2013","unstructured":"Khasa YP, Khushoo A, Mukherjee KJ (2013) Enhancing toxic protein expression in Escherichia coli fed-batch culture using kinetic parameters: human granulocyte-macrophage colony-stimulating factor as a model system. J Biosci Bioeng 115:291\u2013297. https:\/\/doi.org\/10.1016\/j.jbiosc.2012.09.015","journal-title":"J Biosci Bioeng"},{"key":"3438_CR43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1134\/s0003683814080031","volume":"50","author":"EN Kosobokova","year":"2014","unstructured":"Kosobokova EN, Skrypnik KA, Pinyugina MV, Shcherbakov AI, Kosorukov VS (2014) Optimization of the refolding of recombinant human granulocyte-macrophage colony-stimulating factor immobilized on affinity sorbent. Appl Biochem Microbiol 50:773\u2013779. https:\/\/doi.org\/10.1134\/s0003683814080031","journal-title":"Appl Biochem Microbiol"},{"key":"3438_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.pep.2015.09.019","volume":"117","author":"X Bao","year":"2016","unstructured":"Bao X, Xu L, Lu X, Jia L (2016) Optimization of dilution refolding conditions for a camelid single domain antibody against human beta-2-microglobulin. Protein Expr Purif 117:59\u201366. https:\/\/doi.org\/10.1016\/j.pep.2015.09.019","journal-title":"Protein Expr Purif"},{"key":"3438_CR45","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1002\/prot.24671","volume":"82","author":"J George","year":"2014","unstructured":"George J, Compton JR, Leary DH, Olson MA, Legler PM (2014) Structural and mutational analysis of a monomeric and dimeric form of a single domain antibody with implications for protein misfolding. Proteins 82:3101\u20133116. https:\/\/doi.org\/10.1002\/prot.24671","journal-title":"Proteins"},{"key":"3438_CR46","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jmb.2004.02.013","volume":"337","author":"L Jespers","year":"2004","unstructured":"Jespers L, Schon O, James LC, Veprintsev D, Winter G (2004) Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold. J Mol Biol 337:893\u2013903. https:\/\/doi.org\/10.1016\/j.jmb.2004.02.013","journal-title":"J Mol Biol"},{"key":"3438_CR47","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3389\/fimmu.2017.01589","volume":"8","author":"M Arbabi-Ghahroudi","year":"2017","unstructured":"Arbabi-Ghahroudi M (2017) Camelid single-domain antibodies: historical perspective and future outlook. Front Immunol 8:1589. https:\/\/doi.org\/10.3389\/fimmu.2017.01589","journal-title":"Front Immunol"},{"key":"3438_CR48","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-animal-021419-083831","volume":"9","author":"S Muyldermans","year":"2021","unstructured":"Muyldermans S (2021) Applications of nanobodies. Annu Rev Anim Biosci 9:401\u2013421. https:\/\/doi.org\/10.1146\/annurev-animal-021419-083831","journal-title":"Annu Rev Anim Biosci"},{"key":"3438_CR49","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/s12951-024-02900-y","volume":"22","author":"E Alexander","year":"2024","unstructured":"Alexander E, Leong KW (2024) Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years. J Nanobiotechnol 22:661. https:\/\/doi.org\/10.1186\/s12951-024-02900-y","journal-title":"J Nanobiotechnol"},{"key":"3438_CR50","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/imr.13381","volume":"328","author":"T Yu","year":"2024","unstructured":"Yu T, Zheng F, He W, Muyldermans S, Wen Y (2024) Single domain antibody: development and application in biotechnology and biopharma. Immunol Rev 328:98\u2013112. https:\/\/doi.org\/10.1111\/imr.13381","journal-title":"Immunol Rev"},{"key":"3438_CR51","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1016\/j.molimm.2008.04.011","volume":"45","author":"I Hmila","year":"2008","unstructured":"Hmila I, Abdallah RB, Saerens D, Benlasfar Z, Conrath K, Ayeb ME, Muyldermans S, Bouhaouala-Zahar B (2008) VHH, bivalent domains and chimeric heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI\u2019. Mol Immunol 45:3847\u20133856. https:\/\/doi.org\/10.1016\/j.molimm.2008.04.011","journal-title":"Mol Immunol"},{"key":"3438_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/bab.67","volume":"59","author":"A Ezzine","year":"2012","unstructured":"Ezzine A, M\u2019Hirsi El Adab S, Bouhaouala-Zahar B, Hmila I, Baciou L, Marzouki MN (2012) Efficient expression of the anti-AahI\u2019 scorpion toxin nanobody under a new functional form in a Pichia pastoris system. Biotechnol Appl Biochem 59:15\u201321. https:\/\/doi.org\/10.1002\/bab.67","journal-title":"Biotechnol Appl Biochem"},{"key":"3438_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2026.02.022","author":"P Stargardt","year":"2026","unstructured":"Stargardt P, Ljungars A, Scheich D, Lingg N, Elmose ES, Ahmadi S, Simon F, Jungbauer A, Mairhofer J, Laustsen AH (2026) One-pot expression of an oligoclonal nanobody-based antivenom in growth-decoupled Escherichia coli. Trends Biotechnol. https:\/\/doi.org\/10.1016\/j.tibtech.2026.02.022","journal-title":"Trends Biotechnol"},{"key":"3438_CR54","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41586-025-09661-0","volume":"647","author":"S Ahmadi","year":"2025","unstructured":"Ahmadi S, Burlet NJ, Benard-Valle M, Guadarrama-Martinez A, Kerwin S, Cardoso IA, Marriott AE, Edge RJ, Crittenden E, Neri-Castro E, Fernandez-Quintero ML, Nguyen GTT, O\u2019Brien C, Wouters Y, Kalogeropoulos K, Thumtecho S, Ebersole TW, Dahl CH, Glegg-Sorensen EU, Jansen T, Boddum K, Manousaki E, Rivera-de-Torre E, Ward AB, Morth JP, Alagon A, Mackessy SP, Ainsworth S, Menzies SK, Casewell NR, Jenkins TP, Ljungars A, Laustsen AH (2025) Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bites. Nature 647:716\u2013725. https:\/\/doi.org\/10.1038\/s41586-025-09661-0","journal-title":"Nature"},{"key":"3438_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.procbio.2024.12.019","volume":"150","author":"S Mohanty","year":"2025","unstructured":"Mohanty S, Talwar M, Chauhan S, Sinha P, Sharma S, Khasa YP (2025) Designing a cost-effective and scalable expression platform for highly efficient recombinant endo-\u03b2-N-acetylglucosaminidase H using fed-batch strategy in E. coli. Process Biochem 150:21\u201332. https:\/\/doi.org\/10.1016\/j.procbio.2024.12.019","journal-title":"Process Biochem"},{"key":"3438_CR56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13568-016-0249-1","volume":"6","author":"X Xue","year":"2016","unstructured":"Xue X, Fan X, Qu Q, Wu G (2016) Bioscreening and expression of a camel anti-CTGF VHH nanobody and its renaturation by a novel dialysis-dilution method. AMB Express 6:72. https:\/\/doi.org\/10.1186\/s13568-016-0249-1","journal-title":"AMB Express"},{"key":"3438_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pep.2017.02.007","volume":"136","author":"M Maggi","year":"2017","unstructured":"Maggi M, Scotti C (2017) Enhanced expression and purification of camelid single domain VHH antibodies from classical inclusion bodies. Protein Expr Purif 136:39\u201344. https:\/\/doi.org\/10.1016\/j.pep.2017.02.007","journal-title":"Protein Expr Purif"},{"key":"3438_CR58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pep.2016.11.005","volume":"131","author":"VK Dagar","year":"2017","unstructured":"Dagar VK, Adivitiya, Khasa YP (2017) High-level expression and efficient refolding of therapeutically important recombinant human Interleukin-3 (hIL-3) in E. coli. Protein Expr Purif 131:51\u201359. https:\/\/doi.org\/10.1016\/j.pep.2016.11.005","journal-title":"Protein Expr Purif"},{"key":"3438_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.pep.2015.12.005","volume":"120","author":"S Ahdi Khosroshahi","year":"2016","unstructured":"Ahdi Khosroshahi S, Farajnia S, Ghiamirad M, Tanomand A, Veisi K, Rahbarnia L, Akbari B (2016) Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR). Protein Expr Purif 120:59\u201364. https:\/\/doi.org\/10.1016\/j.pep.2015.12.005","journal-title":"Protein Expr Purif"},{"key":"3438_CR60","doi-asserted-by":"publisher","first-page":"835","DOI":"10.34248\/bsengineering.1839753","volume":"9","author":"G Terlemez","year":"2026","unstructured":"Terlemez G, Arkca I, Aydin E, Ta\u015fkent Sezgin H (2026) Investigation of the effect of arginine and glutathione on recovery of a single domain antibody produced in bacteria in inclusion bodies. Black Sea J Eng Sci 9:835\u2013844. https:\/\/doi.org\/10.34248\/bsengineering.1839753","journal-title":"Black Sea J Eng Sci"},{"key":"3438_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.pep.2025.106875","volume":"239","author":"OM Bhikhabhai","year":"2026","unstructured":"Bhikhabhai OM, Kumar H (2026) Novel anti-NS1 human single domain antibody from Dengue infected NS1 positive patients. Protein Expr Purif 239:106875. https:\/\/doi.org\/10.1016\/j.pep.2025.106875","journal-title":"Protein Expr Purif"},{"key":"3438_CR62","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.ijbiomac.2022.04.078","volume":"209","author":"MS Babbal","year":"2022","unstructured":"Babbal, Mohanty S, Dabburu GR, Kumar M, Khasa YP (2022) Heterologous expression of novel SUMO proteases from Schizosaccharomyces pombe in E. coli: catalytic domain identification and optimization of product yields. Int J Biol Macromol 209:1001\u20131019. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.04.078","journal-title":"Int J Biol Macromol"},{"key":"3438_CR63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.enzmictec.2018.05.004","volume":"116","author":"S Bindal","year":"2018","unstructured":"Bindal S, Dagar VK, Saini M, Khasa YP, Gupta R (2018) High level extracellular production of recombinant gamma-glutamyl transpeptidase from Bacillus licheniformis in Escherichia coli fed-batch culture. Enzyme Microb Technol 116:23\u201332. https:\/\/doi.org\/10.1016\/j.enzmictec.2018.05.004","journal-title":"Enzyme Microb Technol"},{"key":"3438_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2859-7-35","volume":"7","author":"CM Hasan","year":"2008","unstructured":"Hasan CM, Shimizu K (2008) Effect of temperature up-shift on fermentation and metabolic characteristics in view of gene expressions in Escherichia coli. Microb Cell Fact 7:35. https:\/\/doi.org\/10.1186\/1475-2859-7-35","journal-title":"Microb Cell Fact"},{"key":"3438_CR65","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1475-2859-9-65","volume":"9","author":"I Peubez","year":"2010","unstructured":"Peubez I, Chaudet N, Mignon C, Hild G, Husson S, Courtois V, De Luca K, Speck D, Sodoyer R (2010) Antibiotic-free selection in E. coli: new considerations for optimal design and improved production. Microb Cell Fact 9:65. https:\/\/doi.org\/10.1186\/1475-2859-9-65","journal-title":"Microb Cell Fact"},{"key":"3438_CR66","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.enzmictec.2008.08.007","volume":"43","author":"J Pinsach","year":"2008","unstructured":"Pinsach J, de Mas C, L\u00f3pez-Sant\u00edn J, Striedner G, Bayer K (2008) Influence of process temperature on recombinant enzyme activity in Escherichia coli fed-batch cultures. Enzyme Microb Technol 43:507\u2013512. https:\/\/doi.org\/10.1016\/j.enzmictec.2008.08.007","journal-title":"Enzyme Microb Technol"},{"key":"3438_CR67","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/10826068.2018.1425709","volume":"48","author":"J Liang","year":"2018","unstructured":"Liang J, Zhao J, Wang Z, Wang Y (2018) Temperature gradient-based high-cell density fed-batch fermentation for the production of pyruvate oxidase by recombinant E. coli. Prep Biochem Biotechnol 48:188\u2013193. https:\/\/doi.org\/10.1080\/10826068.2018.1425709","journal-title":"Prep Biochem Biotechnol"},{"key":"3438_CR68","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00253-021-11093-5","volume":"105","author":"SM Alonso Villela","year":"2021","unstructured":"Alonso Villela SM, Ghezal-Kraiem H, Bouhaouala-Zahar B, Bideaux C, Aceves Lara CA, Fillaudeau L (2021) Effect of temperature on the production of a recombinant antivenom in fed-batch mode. Appl Microbiol Biotechnol 105:1017\u20131030. https:\/\/doi.org\/10.1007\/s00253-021-11093-5","journal-title":"Appl Microbiol Biotechnol"},{"key":"3438_CR69","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/elsc.201900158","volume":"20","author":"L Rezaei","year":"2020","unstructured":"Rezaei L, Shojaosadati SA, Farahmand L, Moradi-Kalbolandi S (2020) Enhancement of extracellular bispecific anti-MUC1 nanobody expression in E. coli BL21 (DE3) by optimization of temperature and carbon sources through an autoinduction condition. Eng Life Sci 20:338\u2013349. https:\/\/doi.org\/10.1002\/elsc.201900158","journal-title":"Eng Life Sci"},{"key":"3438_CR70","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.tibtech.2023.03.002","volume":"41","author":"L Becker","year":"2023","unstructured":"Becker L, Sturm J, Eiden F, Holtmann D (2023) Analyzing and understanding the robustness of bioprocesses. Trends Biotechnol 41:1013\u20131026. https:\/\/doi.org\/10.1016\/j.tibtech.2023.03.002","journal-title":"Trends Biotechnol"}],"container-title":["Bioprocess and Biosystems Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00449-026-03438-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00449-026-03438-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00449-026-03438-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:57:43Z","timestamp":1792011463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00449-026-03438-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":70,"alternative-id":["3438"],"URL":"https:\/\/doi.org\/10.1007\/s00449-026-03438-z","relation":{},"ISSN":["1615-7591","1615-7605"],"issn-type":[{"value":"1615-7591","type":"print"},{"value":"1615-7605","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"15 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}